176 related articles for article (PubMed ID: 8555063)
1. Hypocellular myelodysplastic syndromes (MDS): new proposals.
Tuzuner N; Cox C; Rowe JM; Watrous D; Bennett JM
Br J Haematol; 1995 Nov; 91(3):612-7. PubMed ID: 8555063
[TBL] [Abstract][Full Text] [Related]
2. Hypocellular myelodysplastic syndromes: clinical and biological significance.
Marisavljevic D; Cemerikic V; Rolovic Z; Boskovic D; Colovic M
Med Oncol; 2005; 22(2):169-75. PubMed ID: 15965280
[TBL] [Abstract][Full Text] [Related]
3. Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Schemenau J; Baldus S; Anlauf M; Reinecke P; Braunstein S; Blum S; Nachtkamp K; Neukirchen J; Strup C; Aul C; Haas R; Gattermann N; Germing U
Eur J Haematol; 2015 Sep; 95(3):181-9. PubMed ID: 25600827
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.
Tuzuner N; Cox C; Rowe JM; Bennett JM
Leuk Res; 1994 Aug; 18(8):559-64. PubMed ID: 8065157
[TBL] [Abstract][Full Text] [Related]
5. Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome.
Bono E; McLornan D; Travaglino E; Gandhi S; Gallì A; Khan AA; Kulasekararaj AG; Boveri E; Raj K; Elena C; Ireland RM; Bianchessi A; Jiang J; Todisco G; Ferretti VV; Cazzola M; Marsh JCW; Malcovati L; Mufti GJ
Leukemia; 2019 Oct; 33(10):2495-2505. PubMed ID: 30940907
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
7. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
8. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
[TBL] [Abstract][Full Text] [Related]
9. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.
Saad ST; Vassallo J; Arruda VA; Lorand-Metze I
Pathologica; 1994 Feb; 86(1):47-51. PubMed ID: 8072801
[TBL] [Abstract][Full Text] [Related]
10. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.
Yue G; Hao S; Fadare O; Baker S; Pozdnyakova O; Galili N; Woda BA; Raza A; Wang SA
Leuk Res; 2008 Apr; 32(4):553-8. PubMed ID: 17888511
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of femoral marrow cellularity in hypocellular haemopoietic disorders.
Lorand-Metze I; Santiago GF; Lima CS; Zanardi VA; Torriani M
Clin Radiol; 2001 Feb; 56(2):107-10. PubMed ID: 11222066
[TBL] [Abstract][Full Text] [Related]
12. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia.
Kitagawa M; Kamiyama R; Kasuga T
Hum Pathol; 1993 Apr; 24(4):359-63. PubMed ID: 8098317
[TBL] [Abstract][Full Text] [Related]
13. Hypoplastic myelodysplastic syndrome.
Nand S; Godwin JE
Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
[TBL] [Abstract][Full Text] [Related]
14. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
16. [Aplastic anemia and myelodysplasia: a not-always-easy distinction].
Sardeo G; Gaion F; Artusi T; Dalla Pria AF; Romano G; Puglisi A
Minerva Med; 1987 Oct; 78(20):1519-22. PubMed ID: 3670695
[TBL] [Abstract][Full Text] [Related]
17. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.
Seymour JF; Bennett JM; List AF; Mufti GJ; Gore SD; Fenaux P; Santini V; Hetzer J; Songer S; Skikne BS; Beach CL
Br J Haematol; 2014 Apr; 165(1):49-56. PubMed ID: 24467613
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
20. DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome.
Ribeiro HL; Maia ARS; de Oliveira RTG; Costa MB; Farias IR; de Paula Borges D; de Sousa JC; Magalhães SMM; Pinheiro RF
J Clin Pathol; 2017 Nov; 70(11):970-980. PubMed ID: 28554891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
